Biohaven Pharmaceutical H...
(BHVN)
undefined
undefined%
At close: undefined
38.47
0.00%
After-hours Dec 13, 2024, 07:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY17 |
Revenue | - | - | 462.51M | - | - | - |
Cost of Revenue | 3.37M | 1.39M | 91.66M | 72.00K | - | - |
Gross Profit | -3.37M | -1.39M | 370.85M | -72.00K | - | - |
Operating Income | -436.05M | -567.93M | -218.90M | -114.51M | -479.12M | - |
Interest Income | 17.73M | - | - | - | - | - |
Pretax Income | -409.55M | -569.84M | -212.43M | -118.67M | -528.39M | - |
Net Income | -408.17M | -570.28M | -213.80M | -118.67M | -528.80M | - |
Selling & General & Admin | 62.77M | 130.86M | 37.41M | 16.05M | 134.45M | - |
Research & Development | 373.28M | 437.07M | 181.49M | 98.46M | 344.67M | - |
Other Expenses | - | -1.91M | 1.21M | - | - | - |
Operating Expenses | 436.05M | 567.93M | 218.90M | 114.51M | 479.12M | - |
Interest Expense | - | - | - | - | -12.71M | - |
Selling & Marketing Expenses | 5.87M | - | - | - | - | - |
Cost & Expenses | 436.05M | 567.93M | 218.90M | 114.51M | 479.12M | - |
Income Tax | -1.38M | 438.00K | 1.37M | -134.30K | 419.00K | - |
Shares Outstanding (Basic) | 71.20M | 44.74M | 35.82M | 35.82M | 48.49M | - |
Shares Outstanding (Diluted) | 71.20M | 44.74M | 35.82M | 35.82M | 48.49M | - |
EPS (Basic) | -5.73 | -12.75 | -5.97 | -3.31 | -10.91 | - |
EPS (Diluted) | -5.73 | -12.75 | -5.97 | -3.31 | -10.91 | - |
EBITDA | -429.14M | -462.80M | -217.51M | -114.43M | -479.12M | - |
Depreciation & Amortization | 6.91M | 1.39M | 1.39M | 72.00K | 171.86K | 52.52K |